CAMAIONI, Emidio
 Distribuzione geografica
Continente #
NA - Nord America 4.162
EU - Europa 3.290
AS - Asia 2.620
SA - Sud America 471
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 10.599
Nazione #
US - Stati Uniti d'America 4.093
SG - Singapore 1.221
UA - Ucraina 669
IE - Irlanda 613
IT - Italia 534
HK - Hong Kong 426
BR - Brasile 405
CN - Cina 396
RU - Federazione Russa 357
DE - Germania 267
SE - Svezia 263
VN - Vietnam 223
FI - Finlandia 197
GB - Regno Unito 107
KR - Corea 97
TR - Turchia 89
FR - Francia 54
PL - Polonia 53
IN - India 35
CA - Canada 30
NL - Olanda 27
CH - Svizzera 25
MX - Messico 25
BE - Belgio 23
AT - Austria 21
JP - Giappone 21
AR - Argentina 20
CZ - Repubblica Ceca 20
BD - Bangladesh 17
ES - Italia 14
GR - Grecia 12
ID - Indonesia 12
RO - Romania 12
UZ - Uzbekistan 12
ZA - Sudafrica 12
CO - Colombia 10
EC - Ecuador 10
CL - Cile 9
EG - Egitto 9
LT - Lituania 9
IL - Israele 8
LB - Libano 8
IQ - Iraq 7
MA - Marocco 7
PK - Pakistan 7
EU - Europa 6
PY - Paraguay 6
PH - Filippine 5
SV - El Salvador 5
AZ - Azerbaigian 4
JO - Giordania 4
VE - Venezuela 4
AM - Armenia 3
DZ - Algeria 3
JM - Giamaica 3
OM - Oman 3
PE - Perù 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
IR - Iran 2
KW - Kuwait 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
SA - Arabia Saudita 2
TH - Thailandia 2
TM - Turkmenistan 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
NE - Niger 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TN - Tunisia 1
Totale 10.595
Città #
Singapore 729
Dublin 608
Chandler 555
Hong Kong 423
Jacksonville 409
San Mateo 336
Boardman 214
Santa Clara 190
Ashburn 181
Perugia 181
Altamura 165
Medford 156
Princeton 154
Dong Ket 119
Moscow 113
Lawrence 105
Wilmington 103
Ann Arbor 97
Seoul 97
Beijing 89
Munich 87
Andover 86
Izmir 74
Los Angeles 72
Redmond 58
Des Moines 55
New York 52
Saint Petersburg 49
São Paulo 39
Ho Chi Minh City 36
The Dalles 36
Piscataway 33
Helsinki 31
Turku 27
Norwalk 23
Dallas 22
Brussels 21
Hanoi 21
San Paolo di Civitate 21
Brooklyn 20
Chicago 19
London 19
Tokyo 18
Woodbridge 18
Denver 16
Rome 16
San Francisco 16
Boston 15
Phoenix 14
Shanghai 14
Warsaw 14
Rio de Janeiro 13
Montreal 12
Nuremberg 12
Orem 12
Bucharest 11
Den Haag 11
Poplar 11
Redwood City 11
Stockholm 11
Auburn Hills 10
Belo Horizonte 10
Charlotte 10
Johannesburg 10
Mexico City 10
Ankara 9
Chennai 9
Houston 9
Milan 9
Zhengzhou 9
Atlanta 8
Falls Church 8
Olomouc 8
Tianjin 8
Brno 7
Cairo 7
Hefei 7
Krakow 7
San Diego 7
Toronto 7
Florence 6
Guangzhou 6
Haiphong 6
Lausanne 6
Mcallen 6
Ness Ziona 6
Renton 6
Simi Valley 6
Tashkent 6
Amsterdam 5
Bogotá 5
Brasília 5
Campinas 5
Curitiba 5
Detroit 5
Frankfurt Am Main 5
Guarulhos 5
Kraków 5
Lappeenranta 5
Ribeirão Preto 5
Totale 6.448
Nome #
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 145
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 142
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 117
Structure-activity relationships of bisphophonate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists 111
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 111
Towards New Neuroprotective Agents: Design and Synthesis of Thieno[2,3-c]-isoquinolinon-5-one as a Potent PARP-1 Inhibitor. 104
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 102
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors 101
Binding Mode of 6ECDCA, a Potent Bile Acid Agonist of the Farnesoid X Receptor (FXR) 101
Spiro[2.2]pentane as a dyssymetric scaffold for conformationally constrained analogues of glutamic acid: diastereodivergent synthesis of 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 101
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 100
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 100
Spiro[2.2]pentane as a Dissymmetric Scaffold for Conformationally Constrained Analogues of Glutamic Acid: Focus on Racemic 1-Aminospiro[2.2]pentyl-1,4-dicarboxylic Acids 99
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 99
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. 98
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 97
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage 95
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. 95
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 95
Metabotropic glutamate receptors: structure and new subtype-selective ligands 94
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 94
Chiral separation of helical chromenes with chloromethyl phenylcarbamate polysaccharide-based stationary phases 93
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. 92
Design and synthesis of 4H-thieno[2,3-c]isoquinolin-5-one derivatives as potent PARP-1 inhibitors, on route of new antiischemic agents 92
Novel PARP Inhibitors: Synthesis and Molecular Modeling Studies 90
Design, Molecular Modeling Studies, Synthesis and Preliminary Evaluation of Novel PARP-1 Inhibitors on the Road of Antiischemic Agents 90
Targeting the FXR nuclear receptor through a virtual screening approach 90
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 90
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 88
PARP inhibitors: polypharmacology versus selective inhibition 88
Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA 87
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis 87
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. 86
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 86
Rat Brain Guanosine Binding Site:Biological Studies and Pseudo Receptor Construction 85
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 85
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 85
Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors 84
Preparation and use of nucleotide bisphosphate as P2Y antagonists 83
Dexpramipexole improves bioenergetics and outcome in experimental stroke 83
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 81
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases 81
Circular Hazelnut Protection by Lignocellulosic Waste Valorization for Nanopesticides Development 81
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 80
Bile acids: property-activity relationship and molecular modelling studies 79
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 78
Effects of new arylazido compounds of pyridoxal phosphate on ecto-ATPase activity of guinea pig tissues 78
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids. 78
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 78
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 77
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 77
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide. 77
The relationship between s. Aureus and branched-chain amino acids content in composite cow milk 77
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and QSAR 76
Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids 76
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 76
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. 76
Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues 75
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 75
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent 74
Branched-chain amino acids as potential diagnostic and prognostic disease biomarkers 73
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 73
Hydrophobic Amino Acid Content in Onions as Potential Fingerprints of Geographical Origin: The Case of Rossa da Inverno sel. Rojo Duro 73
Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogues: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 72
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 72
Rat brain guanosine binding site. Biological studies and pseudo-Receptor construction 71
8-Bromo-9-etiladenine come tools per l’ottenimento di antagonisti selettivi per il recettore adenosinico A2B 71
Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C 69
Pharmacology of the highly selective A1 adenosine receptor agonist2-chloro-N6-cyclopentyladenosine. 67
Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) 67
Molecular determinats for metabotropic glutamate receptor activation and blockade. Molecular dynamics and electrostatic potential analysis studies 67
Insights in the PARP1 poisoning effect 67
Synthesis and Biological Evaluation of 2-(3’-(1H-tetrazol-5-yl)bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 Receptor 66
Fast chromatographic determination of the bile salt critical micellar concentration 66
Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 66
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure Activity Relationship of a Series of Body and Side Chain Modified Analogs of Chenodeoxycholic Acid 66
Synthesis, molecular modelling and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO) 65
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 65
A Green Nanostructured Pesticide to Control Tomato Bacterial Speck Disease 65
The relationships between somatic cells and isoleucine, leucine and tyrosine content in cow milk 64
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 63
Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase 63
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 63
Boosting Immunity and Management against Wheat Fusarium Diseases by a Sustainable, Circular Nanostructured Delivery Platform 62
Quantitative analysis of cucurbitane-type triterpenes in Ibervillea sonorae extracts: Relationship study with their antiproliferative activity 62
Dominant Factors Affecting the Chromatographic Behaviour of Bile Acids 61
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 61
Stereoselective Synthesis and Preliminary Evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): Identification of (+)-3-MATIDA as a Novel mGluR1 Competitive Antagonist 60
Use of RP-HPLC on a Dynamically Coated Artificial Membrane to Predict Intestinal Absorption of Bile Acids 60
Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin 60
Heterocycles as Companions on Route to Drug Discovery 60
Synthesis and Receptor Affinity of Polysubstituted Adenosines 60
Xaa-prolyl dipeptidyl aminopeptidase may play an important role in biofilm formation by Streptococcus mutans 60
Compendio teorico-pratico di analisi farmaceutica. Riconoscimento delle sostanze solide iscritte nelle vigenti farmacopee 60
Studies on the interaction between PARP’s catalytic site and inhibitors. Design and synthesis of new class of inhibitor derivatives 59
Novel Isoquinoline-Derived Inhibitors of Poly(ADP-Ribose) Polymerase-1: Pharmacological Characterization and Neuroprotective Effects in an in Vitro Model of Cerebral Ischemia 59
Heterocycles as companions on route to drug discovery 58
Combined strategies toward the design and synthesis, of novel inhibitors of indoleamine-2,3-dioxygenase (IDO) 58
High-throughput chromatographic determination of the bile acid critical micellar concentration 58
Towards Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 58
Totale 7.985
Categoria #
all - tutte 53.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021684 0 0 0 0 0 69 121 29 169 32 119 145
2021/20221.214 33 212 11 54 37 11 13 405 43 51 138 206
2022/20232.058 165 391 30 121 178 215 3 83 760 7 76 29
2023/2024851 47 104 44 12 7 15 182 29 88 28 132 163
2024/20252.064 22 202 73 62 252 105 122 93 442 154 319 218
2025/20262.180 339 357 251 529 591 113 0 0 0 0 0 0
Totale 11.010